The meta-analysis showed a significant heterogeneity (I2 = 83%) among these studies, and revealed that GLIPR1 hypermethylation was associated with the increased risk of leukemia (P = 0.0002, OR = 5.96, 95% CI = 2.29–15.46). Here, GLIPR1 is linked to leukemia.